Skip to content

Achieve Life Sciences ACHV Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$6.42-51.5%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

Based on the most recent quarter.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's book value per share?
Achieve Life Sciences (ACHV) reported book value per share of $0.20 in Q1 2026.
How has Achieve Life Sciences's book value per share changed year-over-year?
Achieve Life Sciences's book value per share decreased by 32.5% year-over-year, from $0.30 to $0.20.
What is the long-term trend for Achieve Life Sciences's book value per share?
Over 5 years (2020 to 2025), Achieve Life Sciences's book value per share has grown at a -48.6% compound annual growth rate (CAGR), from $13.71 to $0.49.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.